Annual Total Liabilities
$332.67 M
-$23.92 M-6.71%
December 31, 2024
Summary
- As of February 7, 2025, CLB annual total liabilities is $332.67 million, with the most recent change of -$23.92 million (-6.71%) on December 31, 2024.
- During the last 3 years, CLB annual total liabilities has fallen by -$87.18 million (-20.77%).
- CLB annual total liabilities is now -48.74% below its all-time high of $648.96 million, reached on December 31, 2015.
Performance
CLB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$332.67 M
-$11.38 M-3.31%
December 31, 2024
Summary
- As of February 7, 2025, CLB quarterly total liabilities is $332.67 million, with the most recent change of -$11.38 million (-3.31%) on December 31, 2024.
- Over the past year, CLB quarterly total liabilities has dropped by -$23.92 million (-6.71%).
- CLB quarterly total liabilities is now -48.96% below its all-time high of $651.73 million, reached on June 30, 2015.
Performance
CLB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CLB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | -6.7% |
| 3 y3 years | -20.8% | -6.7% |
| 5 y5 years | -43.9% | -6.7% |
CLB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.8% | at low | -20.8% | at low |
| 5 y | 5-year | -43.9% | at low | -43.9% | at low |
| alltime | all time | -48.7% | +1083.9% | -49.0% | +1209.7% |
Core Laboratories NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $332.67 M(-6.7%) | $332.67 M(-3.3%) |
| Sep 2024 | - | $344.05 M(-2.3%) |
| Jun 2024 | - | $352.11 M(+0.4%) |
| Mar 2024 | - | $350.53 M(-1.7%) |
| Dec 2023 | $356.59 M(-8.4%) | $356.59 M(-1.8%) |
| Sep 2023 | - | $362.96 M(-5.0%) |
| Jun 2023 | - | $382.24 M(-2.9%) |
| Mar 2023 | - | $393.47 M(+1.0%) |
| Dec 2022 | $389.40 M(-7.3%) | $389.40 M(+0.6%) |
| Sep 2022 | - | $386.90 M(-4.2%) |
| Jun 2022 | - | $403.77 M(-3.5%) |
| Mar 2022 | - | $418.53 M(-0.3%) |
| Dec 2021 | $419.85 M(-14.8%) | $419.85 M(-1.3%) |
| Sep 2021 | - | $425.26 M(-4.2%) |
| Jun 2021 | - | $444.08 M(+1.3%) |
| Mar 2021 | - | $438.40 M(-11.1%) |
| Dec 2020 | $493.01 M(-16.8%) | $493.01 M(-5.0%) |
| Sep 2020 | - | $519.11 M(-5.3%) |
| Jun 2020 | - | $548.29 M(-4.9%) |
| Mar 2020 | - | $576.53 M(-2.7%) |
| Dec 2019 | $592.53 M(+21.4%) | $592.53 M(-0.1%) |
| Sep 2019 | - | $593.13 M(+0.7%) |
| Jun 2019 | - | $589.03 M(-2.5%) |
| Mar 2019 | - | $604.41 M(+23.9%) |
| Dec 2018 | $487.93 M(+11.9%) | $487.93 M(-3.4%) |
| Sep 2018 | - | $505.19 M(+13.0%) |
| Jun 2018 | - | $446.97 M(+0.3%) |
| Mar 2018 | - | $445.56 M(+2.2%) |
| Dec 2017 | $436.08 M(+4.4%) | $436.08 M(+1.5%) |
| Sep 2017 | - | $429.45 M(-0.7%) |
| Jun 2017 | - | $432.31 M(+1.2%) |
| Mar 2017 | - | $427.07 M(+2.2%) |
| Dec 2016 | $417.75 M(-35.6%) | $417.75 M(+4.6%) |
| Sep 2016 | - | $399.34 M(-1.4%) |
| Jun 2016 | - | $405.15 M(-34.1%) |
| Mar 2016 | - | $615.23 M(-5.2%) |
| Dec 2015 | $648.96 M(+12.0%) | $648.96 M(+1.2%) |
| Sep 2015 | - | $641.02 M(-1.6%) |
| Jun 2015 | - | $651.73 M(+9.1%) |
| Mar 2015 | - | $597.46 M(+3.1%) |
| Dec 2014 | $579.33 M(+17.8%) | $579.33 M(-0.7%) |
| Sep 2014 | - | $583.36 M(+5.5%) |
| Jun 2014 | - | $552.85 M(+7.7%) |
| Mar 2014 | - | $513.43 M(+4.4%) |
| Dec 2013 | $491.62 M(+9.6%) | $491.62 M(+3.9%) |
| Sep 2013 | - | $473.19 M(+1.2%) |
| Jun 2013 | - | $467.64 M(+0.0%) |
| Mar 2013 | - | $467.54 M(+4.2%) |
| Dec 2012 | $448.60 M(+4.5%) | $448.60 M(+11.7%) |
| Sep 2012 | - | $401.70 M(+0.8%) |
| Jun 2012 | - | $398.52 M(+0.5%) |
| Mar 2012 | - | $396.41 M(-7.6%) |
| Dec 2011 | $429.22 M(+24.9%) | $429.22 M(+1.0%) |
| Sep 2011 | - | $424.85 M(+41.6%) |
| Jun 2011 | - | $300.03 M(-4.5%) |
| Mar 2011 | - | $314.26 M(-8.6%) |
| Dec 2010 | $343.70 M | $343.70 M(-13.4%) |
| Sep 2010 | - | $397.04 M(-5.1%) |
| Jun 2010 | - | $418.27 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $387.44 M(+2.9%) |
| Dec 2009 | $376.41 M(+13.0%) | $376.41 M(+10.5%) |
| Sep 2009 | - | $340.74 M(+0.5%) |
| Jun 2009 | - | $338.95 M(+1.4%) |
| Mar 2009 | - | $334.36 M(+0.3%) |
| Dec 2008 | $333.25 M(-24.5%) | $333.25 M(-24.0%) |
| Sep 2008 | - | $438.40 M(-1.1%) |
| Jun 2008 | - | $443.11 M(-0.8%) |
| Mar 2008 | - | $446.74 M(+1.3%) |
| Dec 2007 | $441.16 M(+3.1%) | $441.16 M(-5.0%) |
| Sep 2007 | - | $464.29 M(+3.7%) |
| Jun 2007 | - | $447.57 M(+3.8%) |
| Mar 2007 | - | $431.01 M(+0.7%) |
| Dec 2006 | $427.93 M(+138.7%) | $427.93 M(+86.9%) |
| Sep 2006 | - | $228.96 M(+5.1%) |
| Jun 2006 | - | $217.83 M(+10.2%) |
| Mar 2006 | - | $197.75 M(+10.3%) |
| Dec 2005 | $179.28 M(-9.2%) | $179.28 M(-0.3%) |
| Sep 2005 | - | $179.85 M(-3.9%) |
| Jun 2005 | - | $187.15 M(-5.8%) |
| Mar 2005 | - | $198.65 M(+0.6%) |
| Dec 2004 | $197.43 M(-3.8%) | $197.43 M(+2.5%) |
| Sep 2004 | - | $192.57 M(-1.6%) |
| Jun 2004 | - | $195.66 M(-0.2%) |
| Mar 2004 | - | $196.05 M(-4.5%) |
| Dec 2003 | $205.25 M(+26.0%) | $205.25 M(+5.8%) |
| Sep 2003 | - | $194.09 M(+7.5%) |
| Jun 2003 | - | $180.56 M(+10.9%) |
| Mar 2003 | - | $162.78 M(-0.1%) |
| Dec 2002 | $162.87 M(-0.1%) | $162.87 M(+14.2%) |
| Sep 2002 | - | $142.58 M(+0.1%) |
| Jun 2002 | - | $142.49 M(-6.8%) |
| Mar 2002 | - | $152.82 M(-6.3%) |
| Dec 2001 | $163.08 M(+0.9%) | $163.08 M(-0.4%) |
| Sep 2001 | - | $163.65 M(+7.4%) |
| Jun 2001 | - | $152.38 M(+4.1%) |
| Mar 2001 | - | $146.33 M(-9.5%) |
| Dec 2000 | $161.65 M(+1.3%) | $161.65 M(+9.5%) |
| Sep 2000 | - | $147.60 M(-2.2%) |
| Jun 2000 | - | $150.90 M(+1.9%) |
| Mar 2000 | - | $148.08 M(-7.2%) |
| Dec 1999 | $159.58 M(+3.8%) | $159.58 M(-6.9%) |
| Sep 1999 | - | $171.40 M(+7.7%) |
| Jun 1999 | - | $159.20 M(+4.8%) |
| Mar 1999 | - | $151.90 M(-1.2%) |
| Dec 1998 | $153.70 M(+14.1%) | $153.70 M(+11.8%) |
| Sep 1998 | - | $137.50 M(-8.1%) |
| Jun 1998 | - | $149.60 M(+25.2%) |
| Mar 1998 | - | $119.50 M(-11.3%) |
| Dec 1997 | $134.70 M(+319.6%) | $134.70 M(-20.7%) |
| Sep 1997 | - | $169.90 M(+1.3%) |
| Jun 1997 | - | $167.70 M(+214.0%) |
| Mar 1997 | - | $53.40 M(+66.4%) |
| Dec 1996 | $32.10 M(+14.2%) | $32.10 M(+26.4%) |
| Sep 1996 | - | $25.40 M(-8.3%) |
| Jun 1996 | - | $27.70 M(-7.7%) |
| Mar 1996 | - | $30.00 M(+6.8%) |
| Dec 1995 | $28.10 M | $28.10 M(+9.8%) |
| Sep 1995 | - | $25.60 M |
FAQ
- What is Core Laboratories NV annual total liabilities?
- What is the all time high annual total liabilities for Core Laboratories NV?
- What is Core Laboratories NV annual total liabilities year-on-year change?
- What is Core Laboratories NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for Core Laboratories NV?
- What is Core Laboratories NV quarterly total liabilities year-on-year change?
What is Core Laboratories NV annual total liabilities?
The current annual total liabilities of CLB is $332.67 M
What is the all time high annual total liabilities for Core Laboratories NV?
Core Laboratories NV all-time high annual total liabilities is $648.96 M
What is Core Laboratories NV annual total liabilities year-on-year change?
Over the past year, CLB annual total liabilities has changed by -$23.92 M (-6.71%)
What is Core Laboratories NV quarterly total liabilities?
The current quarterly total liabilities of CLB is $332.67 M
What is the all time high quarterly total liabilities for Core Laboratories NV?
Core Laboratories NV all-time high quarterly total liabilities is $651.73 M
What is Core Laboratories NV quarterly total liabilities year-on-year change?
Over the past year, CLB quarterly total liabilities has changed by -$23.92 M (-6.71%)